These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16439872

  • 1. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.
    Lemoine M, Barbu V, Girard PM, Kim M, Bastard JP, Wendum D, Paye F, Housset C, Capeau J, Serfaty L.
    AIDS; 2006 Feb 14; 20(3):387-95. PubMed ID: 16439872
    [Abstract] [Full Text] [Related]

  • 2. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients.
    Jan V, Cervera P, Maachi M, Baudrimont M, Kim M, Vidal H, Girard PM, Levan P, Rozenbaum W, Lombès A, Capeau J, Bastard JP.
    Antivir Ther; 2004 Aug 14; 9(4):555-64. PubMed ID: 15456087
    [Abstract] [Full Text] [Related]

  • 3. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
    McPherson S, Jonsson JR, Barrie HD, O'Rourke P, Clouston AD, Powell EE.
    J Hepatol; 2008 Dec 14; 49(6):1046-54. PubMed ID: 18752865
    [Abstract] [Full Text] [Related]

  • 4. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
    Moreno-Torres A, Domingo P, Pujol J, Blanco-Vaca F, Arroyo JA, Sambeat MA.
    Antivir Ther; 2007 Dec 14; 12(2):195-203. PubMed ID: 17503662
    [Abstract] [Full Text] [Related]

  • 5. [Expression and action of hepatic sterol regulatory element-binding protein-1c in patients with nonalcoholic fatty liver disease].
    Yang ZX, Sun H, Shen W.
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov 14; 16(11):823-6. PubMed ID: 19032865
    [Abstract] [Full Text] [Related]

  • 6. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
    Oikari S, Ahtialansaari T, Huotari A, Kiehne K, Fölsch UR, Wolffram S, Jänne J, Alhonen L, Herzig KH.
    Acta Physiol (Oxf); 2008 Sep 14; 194(1):57-65. PubMed ID: 18394026
    [Abstract] [Full Text] [Related]

  • 7. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy.
    Andersen O, Eugen-Olsen J, Kofoed K, Iversen J, Haugaard SB.
    J Med Virol; 2008 Feb 14; 80(2):209-16. PubMed ID: 18098145
    [Abstract] [Full Text] [Related]

  • 8. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).
    Ahmed MH, Byrne CD.
    Drug Discov Today; 2007 Sep 14; 12(17-18):740-7. PubMed ID: 17826687
    [Abstract] [Full Text] [Related]

  • 9. Adipocyte-derived hormone levels in HIV lipodystrophy.
    Kosmiski L, Kuritzkes D, Lichtenstein K, Eckel R.
    Antivir Ther; 2003 Feb 14; 8(1):9-15. PubMed ID: 12713059
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M, Ratziu V, Kim M, Maachi M, Wendum D, Paye F, Bastard JP, Poupon R, Housset C, Capeau J, Serfaty L.
    Liver Int; 2009 Oct 14; 29(9):1431-8. PubMed ID: 19422483
    [Abstract] [Full Text] [Related]

  • 12. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.
    Sutinen J, Kannisto K, Korsheninnikova E, Fisher RM, Ehrenborg E, Nyman T, Virkamäki A, Funahashi T, Matsuzawa Y, Vidal H, Hamsten A, Yki-Järvinen H.
    Am J Physiol Endocrinol Metab; 2004 Jun 14; 286(6):E941-9. PubMed ID: 14749206
    [Abstract] [Full Text] [Related]

  • 13. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
    Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Enjoji M, Takayanagi R, Nakamuta M.
    Int J Mol Med; 2008 Apr 14; 21(4):507-11. PubMed ID: 18360697
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
    Haugaard SB, Andersen O, Vølund A, Hansen BR, Iversen J, Andersen UB, Nielsen JO, Madsbad S.
    Clin Endocrinol (Oxf); 2005 Mar 14; 62(3):354-61. PubMed ID: 15730419
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction.
    Pettinelli P, Videla LA.
    J Clin Endocrinol Metab; 2011 May 14; 96(5):1424-30. PubMed ID: 21325464
    [Abstract] [Full Text] [Related]

  • 19. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN, Tao RY, Tian JY, Liu GT, Ye F.
    Life Sci; 2008 May 07; 82(19-20):983-90. PubMed ID: 18417155
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.